It is our great pleasure to announce that Ivan Durovcik decided to join Glycanostics team as Chief Operating Officer in October 2025. Ivan brings more than 15 years of experience working for Novartis and Sandoz as CFO in Slovakia, Poland, Slovenia, as well as cluster CFO for Eastern Europe.

We are looking forward to creating together a world, where cancer will be diagnosed early and treated successfully!